TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/24 19:44 | 5/13/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | M.d | 229 | 19.57 | 0 | 12 | 4 | 339 | D | |||||||||||||||
5/15/24 19:44 | 5/13/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | S.d | -233 | 21.37 | 0 | -11 | -3 | 339 | D | |||||||||||||||
3/14/23 20:22 | 3/10/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | M.d | 252 | 6.30 | 0 | 40 | 14 | 317 | D | |||||||||||||||
3/14/23 20:22 | 3/10/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | S.d | -254 | 16.61 | 0 | -15 | -5 | 317 | D | |||||||||||||||
4/6/22 20:08 | 4/4/22 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | M.d | 125 | 3.13 | 0 | 40 | 17 | 273 | D | |||||||||||||||
4/6/22 20:08 | 4/4/22 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | S.d | -154 | 23.00 | 0 | -7 | -2 | 273 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |